Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

144.72
Delayed Data
As of Feb 12
 +3.26 / +2.30%
Today’s Change
130.09
Today|||52-Week Range
181.81
-10.85%
Year-to-Date
AMGN Regular Dividend: AMGN began trading ex-dividend on 02/11/16. A $1.00 dividend will be paid to shareholders of record as of 02/16/16.

Today’s Trading

Previous close141.46
Today’s open143.13
Day’s range141.14 - 144.97
Volume3,217,966
Average volume (3 months)3,819,175
Market cap$109.2B
Dividend yield2.76%
Data as of 3:59pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+4.41%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+8.12%
P/E ratio17.3
Price/Sales5.74
Price/Book3.89

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+2.08+2.38%
BIIBBiogen+2.11+0.86%
BXLTBaxalta Inc+1.65+4.46%
BAXBaxter International...+0.73+2.03%
Data as of 4:03pm ET, 02/12/2016

Financials

Next reporting dateApril 19, 2016
EPS forecast (this quarter)$2.59
Annual revenue (last year)$21.7B
Annual profit (last year)$6.9B
Net profit margin32.03%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhavan Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts

Partner Offers